clinical trials

By Dave Muoio 11:47 am July 29, 2019
Last week, Eko Devices announced a new service that matches ECG and heart sound recordings with clinical data to help pinpoint novel drug-data combinations. The Silicon Valley startup is pitching the platform, called Eko Home, as a resource for clinical trials targeting new therapies. The new platform is already seeing some action. According to the company, an ongoing Mayo Clinic study exploring...
By Nathan Eddy 03:27 pm July 3, 2019
Cloud technology opens up the potential for exciting innovations when it comes to the design and execution of clinical trials, but data security and privacy concerns are holding innovation at a snail’s pace.  Despite these misgivings, cloud-based solutions could in fact offer greater security, as well as the ability to access large pools of data that would improve an organization’s ability to...
By Jonah Comstock 02:41 pm March 29, 2019
At MEDinIsrael 2019 this week, a conference in Tel Aviv sponsored by the Israeli Export Institute, Dr. Lena Granovsky, director of analytics and big data at Teva Pharmaceuticals, spoke on and off stage about the work the top Israeli pharma company has been doing in digital health. These topics included the company's recently FDA-cleared smart inhaler ProAir Digihaler, as well as more broad...

Photo courtesy Fitabase.

By Jonah Comstock 07:07 am February 27, 2019
Researchers who use Fitabase to capture data from Fitbit and Garmin devices will soon be able to capture a new kind of data: continuous glucose monitoring data from Dexcom products. The ability to capture glucose values, as well as calibrations, syncs, and alerts, from Dexcom CGMs will allow researchers to study the interplay between blood glucose and the activity, heart rate, and sleep — the...
By Laura Lovett 11:12 am February 20, 2019
Looking to innovate in the research space, pharma giant Pfizer inked a deal with Ochsner Health System, a Louisiana academic healthcare system, to develop digital tools for clinical trials. The partners will be using Ochsner’s innovation lab, innovationOchsner, and Ochsner Research.  The multi-year strategic alliance revolves around a goal of improving “access and connectivity to clinical trials...

Prof. Boaz Lerner of Ben-Gurion University with the new platform for predicting ALS progression​. Credit: BGU

By Dean Koh 11:35 pm February 19, 2019
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), today unveiled an artificial intelligence (AI) platform for monitoring and predicting the progression of neurodegenerative diseases for the purpose of identifying markers for personalised patient care and improved drug development. Developed by Prof. Boaz Lerner of the Department of Industrial Engineering and...
By Dave Muoio 02:18 pm February 18, 2019
Teckro, a Limerick, Ireland-based maker of clinical trial software, has raised $25 million in Series C funding, bringing the company’s total backing to $43 million. TechCrunch, Reuters and others report that the round was led by Northpond Ventures, with additional support from Section 32, Founders Fund, Sands Capital Ventures and Borealis Ventures. What they do Teckro’s digital offering collects...
By Jack Kaufman 11:04 am November 30, 2018
About the Author: Jack is a marketing and community associate at Dreamit, where he focuses on sourcing and evaluating health tech startups and creating opportunities for Dreamit to engage with the startup ecosystem in New York City and beyond. Before joining Dreamit, Jack worked as an associate at Bombas, a mission-driven, high-end apparel startup. He graduated cum laude from Haverford College...

Novartis' recently-opened digital health innovation lab in San Francisco. Photo courtesy Novartis on Twitter.

By Jonah Comstock 01:25 pm November 21, 2018
Last month, Novartis announced that it would be cutting 2,200 jobs as part of a restructuring of the company focusing on particular priorities. “The overall strategy we have is to focus the company as a leading medicines company powered by digital technologies,” CEO Vas Narasimhan told STAT News last month. “What that has meant is to exit certain health care sectors or segments … — so we exited...